Evaluation of various biomarkers as potential mediators of the association between Δ5 desaturase, Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European prospective investigation into cancer and nutrition-potsdam study

American Journal of Clinical Nutrition

Volumn 102, Issue 1, 2015, Pages 155-164

  Jacobs, Simone ^a,c   Schiller, Katja ^a,c   Jansen, Eugene H J M ^b   Boeing, Heiner ^a   Schulze, Matthias B ^a,c   Kröger, Janine ^a,c  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Biomarkers; Diabetes mellitus type 2; Erythrocyte fatty acids; Mediator analysis; Stearoyl coenzyme A desaturase; 5 desaturase; 6 desaturase

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ADIPONECTIN; ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FETUIN A; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLEOYL COENZYME A DESATURASE; TRIACYLGLYCEROL; DELTA-5 FATTY ACID DESATURASE;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DIABETIC PATIENT; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; EXAMINATION; FATTY LIVER; FEMALE; FOLLOW UP; HUMAN; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; WAIST CIRCUMFERENCE; BLOOD; CAUCASIAN; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; EUROPE; INCIDENCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE;

ADIPONECTIN; ADULT; ALANINE TRANSAMINASE; ALPHA-2-HS-GLYCOPROTEIN; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACID DESATURASES; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INCIDENCE; LINOLEOYL-COA DESATURASE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; STEAROYL-COA DESATURASE; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84937430843     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.102707     Document Type: Article

References (51)

1. Bjermo H, Riserus U. Role of hepatic desaturases in obesity-related metabolic disorders. Curr Opin Clin Nutr Metab Care 2010;13:703-8.
2. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008;47:348-80.
3. Kroger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Doring F, Joost HG, Boeing H, Schulze MB. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011;93: 127-42.
4. Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B. Fatty acid profile of the erythrocyte membrane preceding development of type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008;18:503-10.
5. Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw K-T, Wareham NJ, Forouhi NG. Fatty acids measured in plasma and erythrocytemembrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 2010;92:1214-22.
6. Chow LS, Li S, Eberly LE, Seaquist ER, Eckfeldt JH, Hoogeveen RC, Couper DJ, Steffen LM, Pankow JS. Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Metabolism 2013;62:100-8.
7. Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr 2012;142: 592S-9.
8. Jump DB, Tripathy S, Depner CM. Fatty acid-regulated transcription factors in the liver. Annu Rev Nutr 2013;33:249-69.
9. Lu Y, Vaarhorst A, Merry AH, Dolle ME, Hovenier R, Imholz S, Schouten LJ, Heijmans BT, Müller M, Slagboom PE, et al. Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. PLoS ONE 2012;7:e41681.
10. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009;41:56-65.
11. Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, Holm H, Sanna S, Kavousi M, Baumeister SE, et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011;43:1131-8.
12. Roke K, Ralston JC, Abdelmagid S, Nielsen DE, Badawi A, El-Sohemy A, Ma DW, Mutch DM. Variation in the FADS1/2 gene cluster alters plasma n-6 PUFA and is weakly associated with hsCRP levels in healthy young adults. Prostaglandins Leukot Essent Fatty Acids 2013;89:257-63.
13. Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E, Sandri M, Friso S, Pizzolo F, Schaeffer L, et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008;88:941-9.
14. Rudkowska I, Julien P, Couture P, Lemieux S, Tchernof A, Barbier O, Vohl MC. Cardiometabolic risk factors are influenced by stearoyl-CoA desaturase (SCD)-1 gene polymorphisms and n-3 polyunsaturated fatty acid supplementation. Mol Nutr Food Res 2014;58:1079-86.
15. Stryjecki C, Roke K, Clarke S, Nielsen D, Badawi A, El-Sohemy A, Ma DWL, Mutch DM. Enzymatic activity and genetic variation in SCD1 modulate the relationship between fatty acids and inflammation. Mol Genet Metab 2012;105:421-7.
16. Arregui M, Buijsse B, Stefan N, Corella D, Fisher E, di Giuseppe R, Coltell O, Knuppel S, Aleksandrova K, Joost HG, et al. Heterogeneity of the stearoyl-CoA desaturase-1 (SCD1) gene and metabolic risk factors in the EPIC-Potsdam study. PLoS ONE 2012;7:e48338.
17. Boeing H, Wahrendorf J, Becker N. EPIC-Germany-a source for studies into diet and risk of chronic diseases. Ann Nutr Metab 1999;43: 195-204.
18. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999;52:1165-72.
19. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Haring HU, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008;57:2762-7.
20. Montonen J, Drogan D, Joost HG, Boeing H, Fritsche A, Schleicher E, Schulze MB, Pischon T. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol 2011;26:29-38.
21. Jäger S, Jacobs S, Kroger J, Stefan N, Fritsche A, Weikert C, Boeing H, Schulze MB. Association between the Fatty Liver Index and risk of type 2 diabetes in the EPIC-Potsdam Study. PLoS One 2015;10:(4).
22. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 2010;10:56.
23. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6:33.
24. Jacobs S, Kroger J, Floegel A, Boeing H, Drogan D, Pischon T, Fritsche A, Prehn C, Adamski J, Isermann B, et al. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam study. Am J Clin Nutr 2014;100:891-900.
25. Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2006;84:427-33.
26. Bergmann MM, Jacobs E, Hoffmann K, Boeing H. Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire. Eur J Epidemiol 2004;19: 411-6.
27. Jacobs S, Schiller K, Jansen E, Fritsche A, Weikert C, di Giuseppe R, Boeing H, Schulze MB, Kroger J. Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPICPotsdam study. Eur J Clin Nutr 2014;68:517-25.
28. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65:1220S-8S.
29. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11.
30. Hoffmann K, Pischon T, Schulz M, Schulze MB, Ray J, Boeing H. A statistical test for the equality of differently adjusted incidence rate ratios. Am J Epidemiol 2008;167:517-22.
31. LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, Penaranda MM, et al. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014;48:467-73.
32. Bergmann MM, Rehm J, Klipstein-Grobusch K, Boeing H, Schutze M, Drogan D, Overvad K, Tjonneland A, Halkjaer J, Fagherazzi G, et al. The association of pattern of lifetime alcohol use and cause of death in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Epidemiol 2013;42:1772-90.
33. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepaa AL, Oresic M, Yki-Jarvinen H. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 2009;58:203-8.
34. Petersson H, Arnlov J, Zethelius B, Riserus U. Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men. Diabetes Res Clin Pract 2010;87: 379-84.
35. Peter A, Cegan A, Wagner S, Elcnerova M, Konigsrainer A, Konigsrainer I, Haring HU, Schleicher ED, Stefan N. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans. Am J Physiol Endocrinol Metab 2011;300:E321.
36. Stefan N, Peter A, Cegan A, Staiger H, Machann J, Schick F, Claussen CD, Fritsche A, Haring HU, Schleicher E. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia 2008;51:648-56.
37. Peter A, Cegan A, Wagner S, Lehmann R, Stefan N, Konigsrainer A, Konigsrainer I, Häring HU, Schleicher E. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem 2009;55: 2113-20.
38. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2009;5:150-9.
39. Do HJ, Chung HK, Moon J, Shin MJ. Relationship between the estimates of desaturase activities and cardiometabolic phenotypes in Koreans. J Clin Biochem Nutr 2011;49:131-5.
40. Gallo S, Egeland G, Meltzer S, Legault L, Kubow S. Plasma fatty acids and desaturase activity are associated with circulating adiponectin in healthy adolescent girls. J Clin Endocrinol Metab 2010;95:2410-7.
41. Petersson H, Basu S, Cederholm T, Riserus U. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middleaged men. Br J Nutr 2008;99:1186-9.
42. Petersson H, Lind L, Hulthe J, Elmgren A, Cederholm T, Riserus U. Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis 2009;203:298-303.
43. Poudel-Tandukar K, Sato M, Ejima Y, Nanri A, Matsushita Y, Imaizumi K, Mizoue T. Relationship of serum fatty acid composition and desaturase activity to C-reactive protein in Japanese men and women. Atherosclerosis 2012;220:520-4.
44. Enzenbach C, Kroger J, Zietemann V, Jansen EH, Fritsche A, Doring F, Boeing H, Schulze MB. Erythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men. Eur J Nutr 2011; 50:625-36.
45. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P, et al. Metaanalysis of genome-wide association studies in .80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011; 123:731-8.
46. Heid IM, Henneman P, Hicks A, Coassin S, Winkler T, Aulchenko YS, Fuchsberger C, Song K, Hivert MF, Waterworth DM, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010;208: 412-20.
47. Cole SR, Hernan MA. Fallibility in estimating direct effects. Int J Epidemiol 2002;31:163-5.
48. Gillingham LG, Harding SV, Rideout TC, Yurkova N, Cunnane SC, Eck PK, Jones PJ. Dietary oils and FADS1-FADS2 genetic variants modulate [13C]a-linolenic acid metabolism and plasma fatty acid composition. Am J Clin Nutr 2013;97:195-207.
49. Sjogren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, Hamsten A, Hellenius ML, Fisher RM. Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Diabetologia 2008;51:328-35.
50. Zietemann V, Kroger J, Enzenbach C, Jansen E, Fritsche A, Weikert C, Boeing H, Schulze MB. Genetic variation of the FADS1 FADS2 gene cluster and n-6 PUFA composition in erythrocyte membranes in the European Prospective Investigation into Cancer and Nutrition-Potsdam study. Br J Nutr 2010;104:1748-59.
51. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008;118:2047-56.